Prophylaxis and Treatment

Previous Page   Next Page


Overview of prophylaxis and treatment of multikinase inhibitor-induced dermatologic side effects

The dermatologic side effects associated with multikinase inhibitor treatment are addressed on this website. This section of the website, ‘Prophylaxis and treatment’, comprises the following sub-sections:

  • What healthcare providers should know and what patients can do : Healthcare providers (HCPs) should know the key treatment principles for multikinase inhibitor-related skin toxicities and the key behavioural and prophylactic measures that can be undertaken by patients to minimise dermatologic side effects
  • Flexible dosing strategies : What healthcare professionals should do to treat side effects of multikinase inhibitor treatment
  • Prophylactic management : Therapeutic principles, which help to minimise the grade and extent of toxicities
  • Reactive management : Information on close monitoring of and early intervention in dermatologic side effects associated with multikinase inhibitors